<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="7235" end="7245" sStart="7084" offset="151" sid="r8.suggest.v.0473" wn="3" wnkey="suggest%2:32:02::" text="Surprisingly, the phosphospecific antiserum did not detect Btk:ER Y223 phosphorylation in response to BCR cross-linking, suggesting that the observed phosphorylation in this case is largely due to the Y551 Lyn transphosphorylation site." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="14328" end="14336" sStart="null" offset="5" sid="r8.suggest.v.0652" wn="3" wnkey="suggest%2:32:02::" text="This suggests that Btk can function independently of catalytic activity, perhaps as an adapter protein, and that Btk-induced PLC?2 phosphorylation is not essential for PLC?2 activation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="8566" end="8573" sStart="null" offset="104" sid="r8.suggest.v.0580" wn="3" wnkey="suggest%2:32:02::" text="Moreover, the relatively weak phosphorylation of cellular proteins induced by Btk:ER does not suggest that Lyn and/or Syk are becoming activated (Fig 1C)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="26089" end="26097" sStart="null" offset="46" sid="r8.suggest.v.0527" wn="3" wnkey="suggest%2:32:02::" text="Together with our Btk:ER data, this suggests that Btk:ER controls sustained ERK activation in B cells by regulating PLC?2 activity." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="24202" end="24212" sStart="null" offset="123" sid="r8.suggest.v.0235" wn="3" wnkey="suggest%2:32:02::" text="Btk:ER induced a sustained calcium signal in parental cells but not in PLC?2-deficient cells (Fig 4B), suggesting that Btk:ER modulates calcium signaling by affecting PLC?2 activity." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2172-2-4.anc" start="21644" end="21649" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="The PMA and ionomycin control induced apoptosis in both cell types (data not &lt;b&gt;shown&lt;/b&gt;)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="557" end="563" sStart="null" offset="132" sid="r11.severe.j.0031" wn="1" wnkey="severe%5:00:00:intense:00" text="The xid mouse, in which Btk is mutated, and the Btk knockout mouse display similar, although somewhat less severe, phenotypes [ 1]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="287" end="293" sStart="null" offset="75" sid="r11.severe.j.0285" wn="1" wnkey="severe%5:00:00:intense:00" text="The B cell antigen receptor (BCR) signaling defect is very severe such that XLA patients have a block in the pro-B to pre-B cell transition and consequently have no mature B cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="557" end="563" sStart="null" offset="132" sid="r11.severe.j.0031" wn="2147483646" wnkey="null" text="The xid mouse, in which Btk is mutated, and the Btk knockout mouse display similar, although somewhat less severe, phenotypes [ 1]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-4.anc" start="11328" end="11333" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Strikingly, upon treatment with 4-HT, WT Btk:ER induced a &lt;b&gt;rapid&lt;/b&gt; calcium mobilization that was at a low level but sustained (Fig 2C)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-4.anc" start="11328" end="11333" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Strikingly, upon treatment with 4-HT, WT Btk:ER induced a &lt;b&gt;rapid&lt;/b&gt; calcium mobilization that was at a low level but sustained (Fig 2C)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-4.anc" start="11328" end="11333" sStart="null" offset="0" sid="null" wn="2147483644" wnkey="null" text="Strikingly, upon treatment with 4-HT, WT Btk:ER induced a &lt;b&gt;rapid&lt;/b&gt; calcium mobilization that was at a low level but sustained (Fig 2C)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-4.anc" start="11328" end="11333" sStart="null" offset="0" sid="null" wn="2147483644" wnkey="null" text="Strikingly, upon treatment with 4-HT, WT Btk:ER induced a &lt;b&gt;rapid&lt;/b&gt; calcium mobilization that was at a low level but sustained (Fig 2C)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-4.anc" start="11328" end="11333" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" text="Strikingly, upon treatment with 4-HT, WT Btk:ER induced a &lt;b&gt;rapid&lt;/b&gt; calcium mobilization that was at a low level but sustained (Fig 2C)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="31732" end="31738" sStart="null" offset="105" sid="null" wn="1" wnkey="normal%3:00:01::" text="The Btk mutations found in XLA patients and the xid mouse show that Btk is required for normal B cell development, but the important pathways activated by Btk have yet to be fully identified." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="31732" end="31738" sStart="null" offset="105" sid="null" wn="3" wnkey="normal%3:00:03::" text="The Btk mutations found in XLA patients and the xid mouse show that Btk is required for normal B cell development, but the important pathways activated by Btk have yet to be fully identified." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="31732" end="31738" sStart="null" offset="105" sid="null" wn="3" wnkey="normal%3:00:03::" text="The Btk mutations found in XLA patients and the xid mouse show that Btk is required for normal B cell development, but the important pathways activated by Btk have yet to be fully identified." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="31732" end="31738" sStart="null" offset="105" sid="null" wn="1" wnkey="normal%3:00:01::" text="The Btk mutations found in XLA patients and the xid mouse show that Btk is required for normal B cell development, but the important pathways activated by Btk have yet to be fully identified." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="31732" end="31738" sStart="null" offset="105" sid="null" wn="2" wnkey="normal%3:00:02::" text="The Btk mutations found in XLA patients and the xid mouse show that Btk is required for normal B cell development, but the important pathways activated by Btk have yet to be fully identified." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-4.anc" start="30282" end="30288" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="In contrast to the pro-apoptotic role for Btk in DT40 cells, Btk appears to play an anti-apoptotic role in &lt;b&gt;mature&lt;/b&gt; B cells in vivo . The mechanism may involve Btk-dependent activation of the transcription factor NF-? B [ 7, 10] and subsequent upregulation of the anti-apoptotic protein Bcl-X L [ 39, 40]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-4.anc" start="401" end="407" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="The B cell antigen receptor (BCR) signaling defect is very severe such that XLA patients have a block in the pro-B to pre-B cell transition and consequently have no &lt;b&gt;mature&lt;/b&gt; B cells." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-4.anc" start="30282" end="30288" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="In contrast to the pro-apoptotic role for Btk in DT40 cells, Btk appears to play an anti-apoptotic role in &lt;b&gt;mature&lt;/b&gt; B cells in vivo . The mechanism may involve Btk-dependent activation of the transcription factor NF-? B [ 7, 10] and subsequent upregulation of the anti-apoptotic protein Bcl-X L [ 39, 40]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-2-4.anc" start="401" end="407" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="The B cell antigen receptor (BCR) signaling defect is very severe such that XLA patients have a block in the pro-B to pre-B cell transition and consequently have no &lt;b&gt;mature&lt;/b&gt; B cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="11383" end="11388" sStart="null" offset="123" sid="r9.level.n.0860" wn="2" wnkey="level%1:26:01::" text="Strikingly, upon treatment with 4-HT, WT Btk:ER induced a rapid calcium mobilization that was at a low level but sustained (Fig 2C)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="30914" end="30922" sStart="null" offset="103" sid="r11.function.n.0339" wn="2" wnkey="function%1:07:00::" text="In addition, mice deficient for Btk and PLC?2 have similar defects in B cell development and function (reviewed in [ 30])." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="15267" end="15275" sStart="null" offset="155" sid="r11.function.n.0258" wn="2" wnkey="function%1:07:00::" text="It is conceivable that a Btk PH domain-PIP3 interaction is important for membrane localization of the complex, and that this function is independent of Btk kinase activity." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="4213" end="4217" sStart="null" offset="149" sid="r9.full.j.0286" wn="2" wnkey="full%5:00:01:whole:00" text="Btk:ER was constructed such that the hormone-binding domain of the estrogen receptor was fused to the COOH-terminus of full length Btk (Fig 1A)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="1305" end="1311" sStart="null" offset="151" sid="r8.family.n.0822" wn="3" wnkey="family%1:14:04::" text="Btk is thought to be activated upon BCR cross-linking by a two-step mechanism involving phosphatidylinositol (PI) 3-kinase and the Src family PTK Lyn (reviewed in references [ 4, 5, 6])." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="19135" end="19142" sStart="null" offset="4" sid="r10.control.n.0257" wn="4" wnkey="control%1:09:02::" text="The control treatment with PMA and ionomycin induced JNK phosphorylation in both cell types (Fig 3B, lanes 6 and 12)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="13367" end="13375" sStart="null" offset="111" sid="r10.control.n.0379" wn="2147483645" wnkey="null" text="Our data is consistent with that of Fluckiger et al [ 8], who proposed that Btk controls BCR-induced calcium signaling by regulating PLC?2 activation, IP3 levels and calcium store depletion." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="6690" end="6697" sStart="null" offset="5" sid="r10.control.n.0312" wn="4" wnkey="control%1:09:02::" text="As a control, 4-HT treatment did not induce phosphorylation of cellular proteins in parental DT40 cells without Btk:ER (data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="13605" end="13611" sStart="null" offset="97" sid="r10.common.j.0698" wn="3" wnkey="common%5:00:00:shared:00" text="Fig 2Cshows that kinase inactive Btk:ER was unable to induce a calcium flux, which, in common with the PLC?2 data (Fig 2A), suggests that kinase activity is required for Btk:ER function." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="27235" end="27246" sStart="null" offset="107" sid="r11.combination.n.0502" wn="1" wnkey="combination%1:14:00::" text="PLC?2-deficient cells also failed to activate JNK in response to anti-? treatment or a combination of anti-? and 4-HT (Fig 5B, lanes 3-4), whereas parental cells did activate JNK following these treatments (Fig 5B, lanes 8-9)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="26696" end="26707" sStart="null" offset="25" sid="r11.combination.n.0060" wn="1" wnkey="combination%1:14:00::" text="Alternatively, since the combination of protein kinase C and calcium signaling is sufficient to activate JNK [ 9, 38], Btk could activate JNK indirectly through activation of PLC?2." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="26696" end="26707" sStart="null" offset="25" sid="r11.combination.n.0060" wn="1" wnkey="combination%1:14:00::" text="Alternatively, since the combination of protein kinase C and calcium signaling is sufficient to activate JNK [ 9, 38], Btk could activate JNK indirectly through activation of PLC?2." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="25423" end="25430" sStart="null" offset="22" sid="r9.appear.v.0143" wn="1" wnkey="appear%2:39:00::" text="Thus Btk:ER appears to induce ERK activation through its capacity to activate PLC?2, and not through a Grb2/Sos pathway." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="13046" end="13053" sStart="null" offset="138" sid="r11.absence.n.0685" wn="1" wnkey="absence%1:26:00::" text="Similarly, in response to 4-HT treatment, the sustained increase in intracellular calcium levels was abrogated in the absence of extracellular calcium (Fig 2D)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-2-4.anc" start="2523" end="2530" sStart="null" offset="68" sid="r11.absence.n.0704" wn="1" wnkey="absence%1:26:00::" text="In contrast, these pathways are completely inhibited in the absence of the Syk/ZAP-70 family tyrosine kinase Syk [ 14]." />
  </sentences>
</list>